Abstract:Abstract Background Breast cancer is the most prevalent and among the most deadly cancers in females. Patients with breast cancer have highly variable survival lengths, indicating a need to identify prognostic biomarkers for personalized diagnosis and treatment. With the development of new technologies such as next-generation sequencing, multi-omics information are becoming available for a more thorough evaluation of a patient’s condition. In this study, we aim to improve breast cancer overall survival prediction by integrating multi-omics data (e.g., gene expression, DNA methylation, miRNA expression, and copy number variations (CNVs)). Methods Motivated by multi-view learning, we propose a novel strategy to integrate multi-omics data for breast cancer survival prediction by applying complementary and consensus principles. The complementary principle assumes each -omics data contains modality-unique information. To preserve such information, we develop a concatenation autoencoder (ConcatAE) that concatenates the hidden features learned from each modality for integration. The consensus principle assumes that the disagreements among modalities upper bound the model errors. To get rid of the noises or discrepancies among modalities, we develop a cross-modality autoencoder (CrossAE) to maximize the agreement among modalities to achieve a modality-invariant representation. We first validate the effectiveness of our proposed models on the MNIST simulated data. We then apply these models to the TCCA breast cancer multi-omics data for overall survival prediction. Results For breast cancer overall survival prediction, the integration of DNA methylation and miRNA expression achieves the best overall performance of 0.641 ± 0.031 with ConcatAE, and 0.63 ± 0.081 with CrossAE. Both strategies outperform baseline single-modality models using only DNA methylation (0.583 ± 0.058) or miRNA expression (0.616 ± 0.057). Conclusions In conclusion, we achieve improved overall survival prediction performance by utilizing either the complementary or consensus information among multi-omics data. The proposed ConcatAE and CrossAE models can inspire future deep representation-based multi-omics integration techniques. We believe these novel multi-omics integration models can benefit the personalized diagnosis and treatment of breast cancer patients.

Learning Clinical Outcomes from Heterogeneous Genomic Data Sources

Learning Genomic Representations to Predict Clinical Outcomes in Cancer

Strategies to integrate multi-omics data for patient survival prediction

A Contrastive-Learning-Based Deep Neural Network for Cancer Subtyping by Integrating Multi-Omics Data

Exploiting common patterns in diverse cancer types via multi-task learning

Interpretable meta-learning of multi-omics data for survival analysis and pathway enrichment

Multi-task deep latent spaces for cancer survival and treatment response prediction

Multi-task deep latent spaces for cancer survival and drug sensitivity prediction

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

Prediction of disease-free survival for precision medicine using cooperative learning on multi-omic data

Predicting cancer outcomes from histology and genomics using convolutional networks

Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer

The TCGA Meta-Dataset Clinical Benchmark

Integrating Heterogeneous Datasets by Using Multimodal Deep Learning

Reducing healthcare disparities using multiple multiethnic data distributions with fine-tuning of transfer learning

Survival Prediction in Lung Cancer through Multi-Modal Representation Learning

Meta-Learning on Augmented Gene Expression Profiles for Enhanced Lung Cancer Detection

LEARNER: Learning Granular Labels from Coarse Labels using Contrastive Learning

PathoGen-X: A Cross-Modal Genomic Feature Trans-Align Network for Enhanced Survival Prediction from Histopathology Images

Integrative survival analysis of breast cancer with gene expression and DNA methylation data

Prognostically Relevant Subtypes and Survival Prediction for Breast Cancer Based on Multimodal Genomics Data